| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Feb 27, 2019Virtual Press Office and PR Newswire: General Trade show news
FIBRA Prologis (BMV:FIBRAPL 14), a leading owner and operator of Class-A industrial real estate in Mexico, today announced that Luis Gutierrez, CEO Prologis Property Mexico and Jorge Girault, SVP...
-
Feb 27, 2019Virtual Press Office and PR Newswire: General Trade show news
Tolero Pharmaceuticals, Inc., a clinical-stage company focused on developing novel therapeutics for hematological and oncological diseases, today announced that new data from five abstracts on the...
-
Feb 27, 2019Virtual Press Office and PR Newswire: General Trade show news
Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (Nasdaq:SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced two...
-
Feb 27, 2019Virtual Press Office and PR Newswire: General Trade show news
Bolt Biotherapeutics, Inc., a biotechnology company focused on unleashing the power of the immune system to achieve anti-tumor immunity in patients with its promising Immune-Stimulating Antibody...
-
Feb 27, 2019Virtual Press Office and PR Newswire: General Trade show news
Nektar Therapeutics (Nasdaq: NKTR) today announced several preclinical data presentations for its immuno-oncology pipeline candidates, bempegaldesleukin* (NKTR-214), a CD122-preferential IL-2...
